Floatz logo

Hydronidone

Chronic Hepatitis B Virus Infection

Beijing Continent Pharmaceutical Co, Ltd.Small moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Chronic Hepatitis B Virus Infection cohort.

Asset / SponsorPhaseRating
Lamivudine
Yonsei University
Phase 4BBB
Entecavir
Beijing Continent Pharmaceutical Co, Ltd.
Phase 4BBB
Tenofovir Disoproxil Fumarate
Ningbo No.2 Hospital
Phase 4BBB
Telbivudine
The Fifth People's Hospital of Suzhou
Phase 4BBB
Adefovir Dipivoxil
Asian-Pacific Alliance of Liver Disease, Beijing
Phase 4BB

View all 25 →

Same molecule, other indications

Hydronidone is also rated in:

fibrotic liver diseaseActive
BB
Indicative · Phase 3
67 / 100
View asset →
hepatitis B virus infectionDormant
CC
Indicative · Phase 1
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →